Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Smoking 1 Rectal Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Nasopharyngeal Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Genetic Diseases, Inborn 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

Capecitabine 13 Fluorouracil 12 Oxaliplatin 9 Nivolumab 9 Radiotherapy 8 Leucovorin 8 Cetuximab 8 Magnetic Resonance Spectroscopy 6 Irinotecan 5 pembrolizumab 4 encorafenib 4 Surgical Procedures, Operative 4 Sigmoidoscopy 4 Radiotherapy, Intensity-Modulated 4 Surveys and Questionnaires 3 Standard of Care 3 Specimen Handling 3 Biopsy 3 Bevacizumab 3 dostarlimab 2 dehydroftorafur 2 atezolizumab 2 XELOX 2 X-Rays 2 Observation 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 Folfox protocol 2 Drug Therapy 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Rectal Neoplasms × Tablets × Clear all

NCT04503694 2026-05-22

REGINA

Jules Bordet Institute

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡